Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
The NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study was a nationwide public health-focused clinical trial that compared the effectiveness of older (first available in the 1950s) and newer (available since the 1990s) antipsychotic medications used to treat schizophrenia. This page provides information about the study.
Questions and Answers
- Questions and Answers about the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE) — Phase 1 Results (September 2005)
News about the CATIE Study
- Limited Access Dataset from the CATIE Schizophrenia Study
- Information on CATIE-Alzheimer's Disease (CATIE-AD), a related study:
- Other studies being conducted by clinical investigators from the CATIE study team include: